Oral Plus Topical Administration of Enrofloxacin-Hydrochloride-Dihydrate for the Treatment of Unresponsive Canine Pyoderma. A Clinical Trial
An outpatient clinical trial on unresponsive deep-bacterial canine pyoderma (UDCP), without a control group, is presented. The chosen treatment was implemented with a new crystal-solvate of enrofloxacin (enrofloxacin HCl-2H<sub>2</sub>O or enro-C), in a dual scheme, i.e., 10 mg/kg/day PO...
Main Authors: | Lilia Gutierrez, Graciela Tapia, Luis Ocampo, Minerva Monroy-Barreto, Hector Sumano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/10/6/943 |
Similar Items
-
Canine pyoderma histopathology: Insights and findings
by: MOHANAMBAL KALIYANNAN, et al.
Published: (2024-07-01) -
Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
by: Hector Sumano, et al.
Published: (2006-02-01) -
Evaluation of a Tasteless Enrofloxacin Pharmaceutical Preparation for Cats. Naive Pooled-Sample Approach to Study Its Pharmacokinetics
by: Lilia Gutierrez, et al.
Published: (2021-08-01) -
In Vitro Efficiency of Antimicrobial Peptides against Staphylococcal Pathogens Associated with Canine Pyoderma
by: Małgorzata Jarosiewicz, et al.
Published: (2020-03-01) -
Assessment of Key Pharmacokinetic Variables of Bioequivalent and Non-bioequivalent Enrofloxacin Preparations under Various Water Management Conditions
by: Hector Sumano, et al.
Published: (2010-07-01)